Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W V Epstein

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|July 30, 1977
Corticosteroids in levamisole-induced agranulocytosisW V Epstein, J P Michalski, N Talal
The Journal of Rheumatology|December 1, 1975
Irreversible bone marrow failure with chlorambucilP Rudd, J F Fries, W V Epstein
The Journal of Laboratory and Clinical Medicine|July 1, 1974
Formation of "amyloid" fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteinsW V Epstein, M Tan, I S Wood
American Journal of Public Health|May 1, 1983
Is health care use equivalent across social groups? A diagnosis-based studyE H Yelin, J S Kramer, W V Epstein
Arthritis and Rheumatism|April 1, 1977
Rheumatology manpower in California. Approaches to assessment of quantitative sufficiencyE H Yelin, C J Henke, W V Epstein
The New England Journal of Medicine|September 17, 1992
Methotrexate for juvenile rheumatoid arthritisW V Epstein, L A Criswell, C J Henke
Arthritis and Rheumatism|July 1, 1983
Social and economic impacts of four musculoskeletal conditions. A study using national community-based dataJ S Kramer, E H Yelin, W V Epstein
Arthritis and Rheumatism|November 1, 1986
Work disability among persons with musculoskeletal conditionsE H Yelin, C J Henke, W V Epstein
Critical Care Medicine|February 1, 1986
Providers as predictors: using outcome predictions in intensive careH S Perkins, A R Jonsen, W V Epstein
Medical Care|March 1, 1986
Health outcomes for a chronic disease in prepaid group practice and fee for service settings. The case of rheumatoid arthritisE H Yelin, M A Shearn, W V Epstein
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|July 30, 1977
Corticosteroids in levamisole-induced agranulocytosisW V Epstein, J P Michalski, N Talal
The Journal of Rheumatology|December 1, 1975
Irreversible bone marrow failure with chlorambucilP Rudd, J F Fries, W V Epstein
The Journal of Laboratory and Clinical Medicine|July 1, 1974
Formation of "amyloid" fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteinsW V Epstein, M Tan, I S Wood
American Journal of Public Health|May 1, 1983
Is health care use equivalent across social groups? A diagnosis-based studyE H Yelin, J S Kramer, W V Epstein
Arthritis and Rheumatism|April 1, 1977
Rheumatology manpower in California. Approaches to assessment of quantitative sufficiencyE H Yelin, C J Henke, W V Epstein
The New England Journal of Medicine|September 17, 1992
Methotrexate for juvenile rheumatoid arthritisW V Epstein, L A Criswell, C J Henke
Arthritis and Rheumatism|July 1, 1983
Social and economic impacts of four musculoskeletal conditions. A study using national community-based dataJ S Kramer, E H Yelin, W V Epstein
Arthritis and Rheumatism|November 1, 1986
Work disability among persons with musculoskeletal conditionsE H Yelin, C J Henke, W V Epstein
Critical Care Medicine|February 1, 1986
Providers as predictors: using outcome predictions in intensive careH S Perkins, A R Jonsen, W V Epstein
Medical Care|March 1, 1986
Health outcomes for a chronic disease in prepaid group practice and fee for service settings. The case of rheumatoid arthritisE H Yelin, M A Shearn, W V Epstein
Pageof 6